Is Corteva (CTVA) a risky stock?
As of July 21, 2026, Clavix grades Corteva (CTVA) A- for risk, a composite score of 84 out of 100 on an A+ to F scale, which puts CTVA in the "low risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind CTVA's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CTVA scores on each, as of July 21, 2026.
What's moving CTVA's risk right now
Company-specific signals Clavix flags behind CTVA's current grade, drawn from recent news and filings as of July 21, 2026.
CTVA faces direct legal exposure as a named defendant in a high-profile state PFAS lawsuit, with potential liabilities tied to historical operations (including EIDP, a former DuPo…
What a A- grade means
On the Clavix A+ to F scale, CTVA's composite of 84 falls in the A band (80–100), read as "low risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CTVA or any security. Grades are risk indicators, not predictions of return. Data may be delayed.